Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial

BACKGROUND: In a randomized controlled trial, we compared the bone mineral densities (BMDs) and blood markers of bone turnover during short-term treatment of osteoporotic women with bisphosphonate alendronate or bazedoxifene, a selective estrogen receptor modulator. METHODS: Ten and eleven patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Hee Soo, Cho, Sung Hee, Park, Moon Seok, Sung, Ki Hyuk, Lee, Kyoung Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206607/
https://www.ncbi.nlm.nih.gov/pubmed/34130365
http://dx.doi.org/10.11005/jbm.2021.28.2.131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206607/
https://www.ncbi.nlm.nih.gov/pubmed/34130365
http://dx.doi.org/10.11005/jbm.2021.28.2.131

Ejemplares similares